Artificial intelligence for automated classification of coronary lesions from computed tomography coronary angiography scans (ALERT)
Learning Objectives
Author Block: V. Verpalen1, C. Coerkamp1, J. J. H. Henriques1, J-F. Paul2, N. R. Planken1; 1Amsterdam/NL, 2Paris/FR
Purpose: The aim of this study was to evaluate the diagnostic performance of a deep-learning model (DLM) for quantifying coronary stenosis on computed tomography coronary angiography (CTCA) using the Coronary Artery Disease-Reporting and Data System (CAD-RADS).
Methods or Background: This single centre retrospective study included 50 patients suspected of coronary artery disease (CAD). All CTCA examinations were obtained in routine clinical practice. Two expert readers and the DLM independently reassessed the CAD-RADS score per patient (n=50) and per vessel (n=150). Binary classification (CAD-RADS 0-2 or 3-5) and six group classification (CAD-RADS 0-5) were used for comparison among the human readers and between the readers and the DLM.
Results or Findings: Interhuman sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy, and Cohen’s kappa for detecting ≥50% stenosis (binary classification) were 86.4, 85.2, 82.6, 88.5, 85.7%, and 0.71 at patient level. Sensitivity, specificity, PPV, NPV, accuracy, and Cohen’s kappa of the DLM for detecting ≥50% stenosis were 100, 69.6, 75.0, 100, 84.1%, and 0.69 at the patient level for reader 1 and 100, 66.7, 71.4, 100, 81.8%, and 0.65 for reader 2 as reference, respectively. For the six group classification at patient level, interhuman agreement was 65.3% and weighted kappa 0.78. For the DLM vs reader 1 and reader 2 this agreement was 54.5 and 56.8%, the weighted kappa was 0.70 and 0.61, respectively.
Conclusion: Ruling out obstructive CAD (≥50% stenosis) by the DLM is safe, considering the 100% sensitivity. The DLM yielded promising results in CAD-RADS classification (0-5). This DLM has potential to support and alert CTCA-readers in clinical practice.
Limitations: The main limitation of the study is that the CAD-RADS distribution present in the study population does not necessarily reflect local clinical practice, which might influence the local performance of the DLM.
Funding for this study: No funding was received for this study.
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: The study was approved by Ethics committee Amsterdam UMC: 2023.0484,